Medications for Mantle Cell Lymphoma

6 results

  • breyanzi

    (Lisocabtagene Maraleucel)
    Juno Therapeutics, Inc.
    Breyanzi is a CD19-directed CAR-T cell immunotherapy for adults with relapsed or refractory large B-cell lymphoma, CLL/SLL, follicular lymphoma, mantle cell lymphoma, or marginal zone lymphoma after 2 or more prior lines of therapy. Not indicated for primary CNS lymphoma.
    Medication Details

  • brukinsa - zanubrutinib capsule

    (Zanubrutinib)
    Beone Medicines Usa, Inc.
    BRUKINSA is a kinase inhibitor for adults with mantle cell lymphoma, Waldenström's macroglobulinemia, chronic lymphocytic leukemia or small lymphocytic lymphoma, relapsed/refractory marginal zone lymphoma, and relapsed/refractory follicular lymphoma (with obinutuzumab).
    Medication Details
    Drug Interactions

  • calquence - acalabrutinib tablet, film coated

    (Acalabrutinib)
    Astrazeneca Pharmaceuticals Lp
    CALQUENCE treats adults with mantle cell lymphoma (MCL) — either previously untreated (with bendamustine and rituximab, when ineligible for stem cell transplant) or after prior therapy — and adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).
    Medication Details
    Drug Interactions

  • jaypirca - pirtobrutinib tablet, coated

    (Pirtobrutinib)
    Eli Lilly And Company
    Jaypirca treats adults with relapsed or refractory mantle cell lymphoma (MCL) after two or more prior therapies including a BTK inhibitor, and adults with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) after a covalent BTK inhibitor.
    Medication Details
    Drug Interactions

  • revlimid - lenalidomide capsule

    (Lenalidomide)
    Celgene Corporation
    Revlimid treats adult patients with multiple myeloma (with dexamethasone or as maintenance after stem cell transplant), transfusion-dependent anemia from low-risk myelodysplastic syndromes with deletion 5q, relapsed mantle cell lymphoma, and previously treated follicular or marginal zone lymphoma (with rituximab).
    Medication Details
    Drug Interactions

  • tecartus

    (Brexucabtagene Autoleucel)
    Kite Pharma, Inc.
    Tecartus is a CD19-directed CAR-T cell immunotherapy for adults with relapsed or refractory mantle cell lymphoma (MCL) or relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).
    Medication Details
    Drug Interactions